|
[1]DING J,WANG H.Multiple interactive factors in hepatocarcinogenesis[J].Cancer Lett,2014,346(1):17-23.
|
|
[2]FAN JG,FARRELL GC.Epidemiology of non-alcoholic fatty liver disease in China[J].J Hepatol,2009,50(1):204-210.
|
|
[3]FAN JG.Epidemiology of alcoholic and nonalcoholic fatty liver disease in China[J].J Gastroenterol Hepatol,2013,28(Suppl 1):11-17.
|
|
[4]STICKEL F,HELLERBRAND C.Non-alcoholic fatty liver disease as a risk factor for hepatocellular carcinoma:mechanisms and implications[J].Gut,2010,59(10):1303-1307.
|
|
[5]de MINICIS S,MARZIONI M,BENEDETTI A,et al.New insights in hepatocellular carcinoma:from bench to bedside[J].Ann Transl Med,2013,1(2):15.
|
|
[6]LINHART KB,GLASSEN K,PECCERELLA T,et al.The generation of carcinogenic etheno-DNA adducts in the liver of patients with nonalcoholic fatty liver disease[J].Hepatobiliary Surg Nutr,2015,4(2):117-123.
|
|
[7]JIANG CM,PU CW,HOU YH,et al.Non alcoholic steatohepatitis a precursor for hepatocellular carcinoma development[J].World J Gastroenterol,2014,20(44):16464-16473.
|
|
[8]YOON HJ,CHA BS.Pathogenesis and therapeutic approaches for non-alcoholic fatty liver disease[J].World J Hepatol,2014,6(11):800-811.
|
|
[9]BAFFY G,BRUNT EM,CALDWELL SH.Hepatocellular carcinoma in non-alcoholic fatty liver disease:an emerging menace[J].J Hepatol,2012,56(6):1384-1391.
|
|
[10]YAMASHITA T,HONDA M,TAKATORI H,et al.Activation of lipogenic pathway correlates with cell proliferation and poor prognosis in hepatocellular carcinoma[J].J Hepatol,2009,50(1):100-110.
|
|
[11]JIANG S,MINTER LC,STRATTON SA,et al.TRIM24 suppresses development of spontaneous hepatic lipid accumulation and hepatocellular carcinoma in mice[J].J Hepatol,2015,62(2):371-379.
|
|
[12]NAGOSHI S.Osteopontin:versatile modulator of liver diseases[J].Hepatol Res,2014,44(1):22-30.
|
|
[13]Mc KEE C,SIGALA B,SOEDA J,et al.Amphiregulin activates human hepatic stellate cells and is upregulated in non alcoholic steatohepatitis[J].Sci Rep,2015,5:8812.
|
|
[14]MIKURIYA Y,TASHIRO H,KOBAYASHI T,et al.Clinicopathological features of hepatocellular carcinoma in patients with nonalcoholic fatty liver disease[J].Langenbecks Arch Surg,2015,400(4):471-476.
|
|
[15]WOLF MJ,ADILI A,PIOTROWITZ K,et al.Metabolic activation of intrahepatic CD8+T cell and NKT cells causes nonalcoholic steatohepatitis and liver cancer via cross-talk with hepato-cytes[J].Cancer Cell,2014,26(4):549-564.
|
|
[16]BIEGHS V,TRAUTWEIN C.Innate immune signaling and gut-liver interactions in non-alcoholic fatty liver disease[J].Hepatobiliary Surg Nutr,2014,3(6):377-385.
|
|
[17]GENTRIC G,MAILLET V,PARADIS V,et al.Oxidative stress promotes pathologic polyploidization in nonalcoholic fatty liver disease[J].J Clin Invest,2015,125(3):981-992.
|
|
[18]NOUREDDIN M,RINELLA ME.Nonalcoholic fatty liver disease,diabetes,obesity,and hepato-cellular carcinoma[J].Clin Liver Dis,2015,19(2):361-379.
|
|
[19]DUAN XY,ZHANG L,FAN JG,et al.NAFLD leads to liver cancer:do we have sufficient evidence?[J].Cancer Lett,2014,345(2):230-234.
|
|
[20]SORRENTINO P,D'ANGELO S,FERBO U,et al.Liver iron excess in patients with hepatocellular carcinoma developed on nonalcoholic steato-hepatitis[J].J Hepatol,2009,50(2):351-357.
|
|
[21]BA Q,HAO M,HUANG H,et al.Iron deprivation suppresses hepatocellular carcinoma growth in experimental studies[J].Clin Cancer Res,2011,17(24):7625-7633.
|
|
[22]KIRSTEIN MM,VOGEL A.The pathogenesis of hepatocellular carcinoma[J].Dig Dis,2014,32(5):545-53.
|
|
[23]NISCHALKE HD,LUTZ P,KRMER B,et al.A common polymorphism in the NCAN gene is associated with hepatocellular carcinoma in alcoholic liver disease[J].J Hepatol,2014,61(5):1073-1079.
|
|
[24]SUN C,FAN JG,QIAO L.Potential epigenetic mechanism in non-alcoholic fatty liver disease[J].Int J Mol Sci,2015,16(3):5161-5179.
|
|
[25]CERMELLI S,RUGGIERI A,MARRERO JA,et al.Circulating microRNAs in patients with chronic hepatitis C and non-alcoholic fatty liver disease[J].PLo S One,2011,6(8):e23937.
|
|
[26]TAKAKI Y,SAITO Y,TAKASUGI A,et al.Silencing of microRNA-122 is an early event during hepatocarcinogenesis from nonalcoholic steatohepatitis[J].Cancer Sci,2014,105(10):1254-1260.
|
|
[27]FRADES I,ANDREASSON E,MATO JM,et al.Integrative genomic signatures of hepatocellular carcinoma derived from nonalcoholic fatty liver disease[J].PLo S One,2015,10(5):e0124544.
|
|
[28]GAGGINI M,MORELLI M,BUZZIGOLI E,et al.Non-alcoholic fatty liver disease(NAFLD)and its connection with insulin resistance,dyslipidemia,atherosclerosis and coronary heart disease[J].Nutrients,2013,5(5):1544-1560.
|
|
[29]STARLEY BQ,CALCAGNO CJ,HARRISON SA.Nonalcoholic fatty liver disease and hepatocellular carcinoma:a weighty connection[J].Hepatology,2010,51(5):1820-1832.
|
|
[30]ROMEO S,KOZLITINA J,XING C,et al.Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease[J].Nat Genet,2008,40(12):1461-1465.
|
|
[31]ODA K,UTO H,MAWATARI S,et al.Clinical features of hepatocellular carcinoma associated with nonalcoholic fatty liver disease:a review of human studies[J].Clin J Gastroenterol,2015,8(1):1-9.
|
|
[32]ALISI A,CECCARELLI S,PANERA N,et al.Causative role of gut microbiota in non-alcoholic fatty liver disease pathogenesis[J].Front Cell Infect Microbiol,2012,2:132.
|
|
[33]TAKEUCHI M,SAKASAI-SAKAI A,TAKATA T,et al.Serum levels of toxic AGEs(TAGE)may be a promising novel biomarker in development and progression of NASH[J].Med Hypotheses,2015,84(5):490-493.
|
|
[34]BERLANGA A,GUIU-JURADO E,PORRAS JA,et al.Molecular pathways in non-alcoholic fatty liver disease[J].Clin Exp Gastroenterol,2014,7:221-239.
|
|
[35]STREBA LA,VERE CC,ROGOVEANU I,et al.Nonalcoholic fatty liver disease,metabolic risk factors,and hepatocellular carcinoma:an open question[J].World J Gastroenterol,2015,21(14):4103-4110.
|
|
[36]YOSHIMOTO S,LOO TM,ATARASHI K,et al.Obesity-induced gut microbial metabolite promotes liver cancer through senescence secretome[J].Nature,2013,499(7456):97-101.
|
|
[37]PARK EJ,LEE JH,YU GY,et al.Dietary and genetic obesity promote liver inflammation and tumorigenesis by enhancing IL-6and TNF expression[J].Cell,2010,140(2):197-208.
|
|
[38]KAR P.Risk factors for hepatocellular carcinoma in India[J].J Clin Exp Hepatol,2014,4(Suppl 3):s34-s42.
|
|
[39]RAFF EJ,KAKATI D,BLOOMER JR,et al.Diabetes mellitus predicts occurrence of cirrhosis and hepatocellular cancer in alcoholic liver and non-alcoholic fatty liver diseases[J].J Clin Transl Hepatol,2015,3(1):9-16.
|
DownLoad: